Text
New Approaches in Cancer Therapy
Introduction, New anticancer drugs: ( Approach to phase I trials in cancer patients, Review of the clinical activities of VP-16, Phase II-III evaluation of cisplatin, Clinical pharmacology and biochemical studies of N-Phosphonacetyl-L-aspartate), Combined modalities treatment: (VM-26 therapy in children with drug-refractory lymphocytic leukemia, Breast cancer studies at the Milan cancer institute: the combined modality experience, Recent trends in the treatment of advanced lung cancer).
No other version available